オーストラリアの血液検査市場動向(~2021)

◆英語タイトル:Australia Haematology Market Outlook to 2021
◆発行会社/調査会社:GlobalData
◆商品コード:GDMECC1259DB
◆発行日:2015年10月1日
◆調査対象地域:オーストラリア
◆産業分野:医療機器
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[オーストラリアの血液検査市場動向(~2021)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Australia Haematology Market Outlook to 2021

Summary

GlobalData’s new report, “Australia Haematology Market Outlook to 2021″, provides key market data on the Australia Haematology market. The report provides value, in millions of US dollars within market segments – Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the Australia Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Haematology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Haematology Market, Australia 9
3.1 Haematology Market, Australia, Revenue ($m), 2007-2014 9
3.2 Haematology Market, Australia, Revenue ($m), 2014-2021 11
3.2.1 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Haematology Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Haemostasis Market, Australia, Revenue ($m), by Segment, 2007-2014 19
3.2.5 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2007-2014 21
3.2.6 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2014-2021 23
3.2.7 Haematology Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2014-2021 25
3.2.8 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2014-2021 27
3.2.9 Haemostasis Market, Australia, Revenue ($m), by Segment, 2014-2021 29
3.2.10 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2014-2021 31
3.3 Haematology Market, Australia, Distribution Share by Revenue ($m), 2013-2014 33
3.4 Haematology Market, Australia, Company Share by Revenue ($m), 2014 34
4 Overview of Key Companies in Australia, Haematology Market 36
4.1 Siemens Healthcare 36
4.1.1 Company Overview 36
4.2 Sysmex Corporation 36
4.2.1 Company Overview 36
4.3 Danaher Corporation 36
4.3.1 Company Overview 36
4.4 F. Hoffmann-La Roche Ltd. 37
4.4.1 Company Overview 37
4.5 Horiba, Ltd. 37
4.5.1 Company Overview 37
4.6 Abbott Laboratories 37
4.6.1 Company Overview 37
4.7 bioMerieux S.A. 37
4.7.1 Company Overview 37
4.8 Bio-Rad Laboratories, Inc. 38
4.8.1 Company Overview 38
4.9 Diagnostica Stago, Inc. 38
4.9.1 Company Overview 38
4.10 Grifols, S.A. 38
4.10.1 Company Overview 38
5 Haematology Market Pipeline Products 39
6 Financial Deals Landscape 40
6.1 Equity Offerings 40
6.1.1 NuSep to Raise Funds through Share Purchase Plan 40
6.2 Partnerships 41
6.2.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 41
7 Appendix 42
7.1 Research Methodology 43
7.1.1 Coverage 43
7.1.2 Secondary Research 43
7.1.3 Primary Research 43
7.1.4 Company Share Analysis 44
7.1.5 Distribution Share Analysis 44
7.2 GlobalData Consulting 44
7.3 Contact Us 44
7.4 Disclaimer 45

1.1 List of Tables
Table 1: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 7: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 13: Haematology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 33
Table 14: Haematology Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 35
Table 15: Haematology Market Pipeline Products 39
Table 16: NuSep to Raise Funds through Share Purchase Plan 40
Table 17: NoemaLife Enters into Distribution Agreement with Horiba Medical 41

1.2 List of Figures
Figure 1: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 7: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 13: Haematology Market, Australia, Company Share (%) 2014 34

*** 掲載企業 ***

Siemens Healthcare
Sysmex Corporation
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Horiba, Ltd.
Abbott Laboratories
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Diagnostica Stago, Inc.
Grifols, S.A.

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDMECC1259DB )"オーストラリアの血液検査市場動向(~2021)" (英文:Australia Haematology Market Outlook to 2021)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。